A new analysis from Accenture found ten companies earned more than one-third (38 percent) of digital health funding last year. The companies and the 2016 funding amounts include:
Via email, Brian Kalis, Accenture’s managing director of digital health, chalked this up to the fact that the aforementioned companies have found a fit for their business models. Additionally, he mentioned many of the companies (like Guardant Health, Jawbone and Health Catalyst) focus on six overarching areas that received the majority of digital health funding.
As part of its assessment, Accenture found 73 percent of investor funding last year went to the following six categories:
Marc Warren, who co-authored the analysis within Accenture Strategy, explained why these six areas stood out.
The provider efficiency category includes tools for payers and providers to boost operational efficiencies. Virtual care/coordination is a theme that will keep growing in popularity, particularly due to current inefficiencies in care delivery. Wearables are a maturing field, and “their ability to detect specific biometrics is increasing, which we forecast will soon clash with clinical grade devices,” Warren said via email.
Personalized medicine investments point toward a future of relying on an individual’s genetics and evidence-based medicine. Better access to data and technology are making enhanced diagnostics a more viable field. Finally, major healthcare players are working to advance data collection, real-time analytics and artificial intelligence.
Accenture’s analysis also found investors are slowly focusing on later stage startups rather than newly minted ones, signaling an evolution in the market.
“Early investments had initially focused on experimentation in new services, solutions or offerings; however, that’s changed, as efforts have seen success and signaled to the market where a solution can create and unlock value,” Kalis said. “As a result, the market is investing to scale where they have seen success and we see a market with more mature companies seeking later stage funding.”
The assessment includes a prediction by Accenture, as well: The digital health funding market will hit $7 billion by the end of 2017.
The market was at $7 billion in 2015, though Accenture anticipated it would be at $4.3 billion. In 2016, it dropped to $6.4 billion. Accenture predicted funding would hit $5.3 billion that year.
To conduct its research, Accenture analyzed over 4,000 companies across the globe. The funding analysis is based on a sample of startups that earned funding between 2008 and 2017.
Photo: MixAll Studio, Getty Images
Pharma companies are forming long-term relationships with patient organizations, a move that is already bearing fruits for both parties.
Adam Chapman, eyeforpharma
Learn about how well executives are dealing with value-based care (VBC) models, and what technologies they’re using to achieve their goals.
Niki Buchanan, Philips Wellcentive
You may be interested
Three takeaways on the VA, VistA and government health ITFrank - Apr 24, 2019
A new study from the U.S. Government Accountability Office dug deeper into what’s happening with the Department of Veterans Affairs and…
People are talking about this Bojack Horseman episode in light of the Las Vegas mass shootingFrank - Apr 24, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/tv/news/bojack-horseman-season-4-thoughts-and-prayers-a7982226.html
Netflix sets release date for ‘terrifying’ supernatural series DarkFrank - Apr 24, 2019
Frank's source: http://www.independent.co.uk/arts-entertainment/tv/news/dark-netflix-release-date-german-language-teaser-trailer-a7982216.html